Randy Milby - Jan 11, 2022 Form 3/A - Amendment Insider Report for Hillstream BioPharma Inc. (HILS)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Randy Milby
Stock symbol: HILS
Transactions as of: Jan 11, 2022
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 1/20/2022, 08:21 AM
Date Of Original Report: Jan 12, 2022
Next filing: Jan 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HILS	Common stock						1.77M	Jan 11, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were omitted from the Reporting Person's original Form 3.

Remarks:

This is the second of the original three Form 3s. This Form 3/A is filed to amend the Form 3 filed by the Reporting Person on January 12, 2022 (the "Original Form 3"). The Original Form 3 is hereby amended by deleting Row 1 of Table II and the corresponding footnote (1), which described the issuance of a note in the amount of $90,000 issued to the Reporting Person on December 16, 2019.